CD274 and neoplasm: Common positive predictive biomarkers in ICI treatment include tumor mutational burden (TMB) study [69], T-cell filtration [70], PD-L1 expression analysis [71], etc. Enhanced PD-L1, TMB, and T-cell infiltration within a tumor correspond to a better ICI treatment response [38].